Magna Investama Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Magna Investama Mandiri Tbk. trades at Rp99 (market cap 351.35B, 12.84M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Magna Investama Mandiri Tbk. is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Magna Investama Mandiri Tbk. is more actively traded (12.84M versus 62.5K). Which is the better fit depends on your goals.
| MGNA | OBAT | |
|---|---|---|
Market Cap | 351.35B | 164.65B |
Volume | 12.84M | 62.5K |
Lot | 128.42K | 625 |
Turnover | 1.35B | 15.03M |
Average Price | 104.98 | 240.55 |
Value | 1.35B | 15.03M |
Indicative Equilibrium Price | 99 | 238 |
Indicative Equilibrium Volume | 288 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Read more on MGNA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →